Compare AKA & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AKA | STIM |
|---|---|---|
| Founded | 2018 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.4M | 120.4M |
| IPO Year | 2021 | 2018 |
| Metric | AKA | STIM |
|---|---|---|
| Price | $10.67 | $3.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $24.33 | $3.00 |
| AVG Volume (30 Days) | 2.7K | ★ 3.5M |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 57.25 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $600,208,000.00 | $52,776,000.00 |
| Revenue This Year | $6.14 | $11.10 |
| Revenue Next Year | $4.89 | $11.92 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 4.44 | N/A |
| 52 Week Low | $8.42 | $0.80 |
| 52 Week High | $16.38 | $3.80 |
| Indicator | AKA | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 47.51 | 72.57 |
| Support Level | $10.38 | $1.21 |
| Resistance Level | $11.70 | N/A |
| Average True Range (ATR) | 0.43 | 0.26 |
| MACD | -0.09 | 0.11 |
| Stochastic Oscillator | 28.55 | 78.57 |
a.k.a. Brands Holding Corp is a portfolio of fashion brands, including Princess Polly, Culture Kings, Petal & Pup, and mnml. Through these brands, the company reaches next-generation consumers who seek fashion inspiration on social media and mainly shop online. The portfolio consists of two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company generates the majority of its revenue from the United States.
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.